Clinical Trial

A Clinical Study of RSS0343 in Healthy Subjects

Name: A Clinical Study of RSS0343 in Healthy Subjects — clinical trial record (NCT07289464)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a phase I study to evaluate the safety, tolerability and pharmacokinetics of RSS0343 following multiple oral doses in healthy subjects, as well as its effects on the QT/QTc interval.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-04.

Status change: Not Yet Recruiting → Recruiting 2026-01-13

Trial Details

NCT Number	NCT07289464
Lead Sponsor	Reistone Biopharma Company Limited
Conditions	Non-cystic Fibrosis Bronchiectasis
Enrollment	48 participants
Start Date	2026-01-04
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-14